Inventor · disambiguated record
Niklas Bergh
Also filed as: BERGH NIKLAS
5 granted patents·7 pending applications·0 citations·filing 2012–2025
64Inventor score
Top patents by PatentIndex Score
12 records- 0173US12245999B2Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formationCERENO SCIENT AB·Filed 2022·Granted Mar 11, 2025·0 cites·17 claims
- 0268US2023094176A1Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitorsCERENO SCIENT AB·Filed 2022·Application pending·0 cites
- 0367US12023311B2Delayed release pharmaceutical formulations comprising valproic acid, and uses thereofCERENO SCIENT AB·Filed 2022·Granted Jul 2, 2024·0 cites·22 claims
- 0466US2025241880A1Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formationCERENO SCIENT AB·Filed 2025·Application pending·0 cites
- 0565US2023364089A1Compounds and compositions for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formationCERENO SCIENT AB·Filed 2023·Application pending·0 cites
- 0664US11400064B2Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formationCERENO SCIENT AB·Filed 2018·Granted Aug 2, 2022·0 cites·9 claims
- 0759US2021060014A1Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitorsCERENO SCIENT AB·Filed 2020·Application pending·0 cites
- 0855US10111845B2Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formationCERENO SCIENT AB·Filed 2015·Granted Oct 30, 2018·0 cites·24 claims
- 0952US11395808B2Delayed release pharmaceutical formulations comprising valproic acid, and uses thereofCERENO SCIENT AB·Filed 2017·Granted Jul 26, 2022·0 cites·18 claims
- 1047US2014051716A1Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitorsLARSSON PIA·Filed 2012·Application pending·0 cites
- 1147US2020179381A1Compounds and compositions for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formationCERENO SCIENT AB·Filed 2017·Application pending·0 cites
- 1245US2017020874A1Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitorsCERENO SCIENT AB·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Niklas Bergh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →